Bleomycin With or Without Electroporation Therapy in Treating Patients With Stage III or Stage IV Melanoma
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Electroporation therapy may enhance the ability of chemotherapy
drugs to enter tumor cells. Combining chemotherapy with electroporation therapy may kill more
tumor cells.
PURPOSE: Randomized phase I trial to compare the effectiveness of bleomycin with or without
electroporation therapy in treating patients who have stage III or stage IV melanoma.
Phase:
Phase 1
Details
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute